Guangzhou Baiyunshan Pharmaceutical Holdings Company LimitedSSE: 600332

Announcement on Change of Subsidiary's Drug Production License

· Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced a change in its subsidiary's drug production license. The subsidiary, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., received approval to expand its production range. This change is expected to enhance the management of export drugs and maintain stable production supply. The company noted that this license update will not have a significant impact on its current performance.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix

Earlier from Guangzhou Baiyunshan Pharmaceutical

Later from Guangzhou Baiyunshan Pharmaceutical

All Guangzhou Baiyunshan Pharmaceutical news releases